Study reveals a link between people with depression who are prescribed newer antipsychotic medications and higher mortality risk. Read More
The antipsychotic medication clozapine can trigger severe obsessive-compulsive symptoms (OCS) in patients. Adding aripiprazole can help manage clozapine-associated OCS. Read More
Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning. Read More
Typical interventions for schizophrenia do not improve long-term outcomes, even when administered early, a new study reports. Read More
During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period. Read More
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications. Read More
Long-term antipsychotic use does not increase the risk of physical morbidity leading to hospitalization. Read More
People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications. Read More
A new study reveals several biomarkers for eating disorders that are apparent two years prior to diagnosis. Read More
A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic. Read More
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications. Read More
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia. Read More
